234 related articles for article (PubMed ID: 26842955)
1. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
2. Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome.
Veeraragavan S; Wan YW; Connolly DR; Hamilton SM; Ward CS; Soriano S; Pitcher MR; McGraw CM; Huang SG; Green JR; Yuva LA; Liang AJ; Neul JL; Yasui DH; LaSalle JM; Liu Z; Paylor R; Samaco RC
Hum Mol Genet; 2016 Aug; 25(15):3284-3302. PubMed ID: 27365498
[TBL] [Abstract][Full Text] [Related]
3. A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome.
Schmid DA; Yang T; Ogier M; Adams I; Mirakhur Y; Wang Q; Massa SM; Longo FM; Katz DM
J Neurosci; 2012 Feb; 32(5):1803-10. PubMed ID: 22302819
[TBL] [Abstract][Full Text] [Related]
4. LTP is Absent in the CA1 Region of the Hippocampus of Male and Female Rett Syndrome Mouse Models.
Asgarihafshejani A; Raveendran VA; Pressey JC; Woodin MA
Neuroscience; 2024 Jan; 537():189-204. PubMed ID: 38036056
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 ubiquitination and sumoylation, in search of a function†.
Kalani L; Kim BH; Vincent JB; Ausió J
Hum Mol Genet; 2023 Dec; 33(1):1-11. PubMed ID: 37694858
[TBL] [Abstract][Full Text] [Related]
6. Suppressor mutations in
Enikanolaiye A; Ruston J; Zeng R; Taylor C; Schrock M; Buchovecky CM; Shendure J; Acar E; Justice MJ
Genome Res; 2020 Apr; 30(4):540-552. PubMed ID: 32317254
[TBL] [Abstract][Full Text] [Related]
7. Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of
Miranda-Lourenço C; Rosa J; Rei N; Belo RF; Lopes AL; Silva D; Vieira C; Magalhães-Cardoso T; Viais R; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003438
[TBL] [Abstract][Full Text] [Related]
8. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.
Lyst MJ; Ekiert R; Ebert DH; Merusi C; Nowak J; Selfridge J; Guy J; Kastan NR; Robinson ND; de Lima Alves F; Rappsilber J; Greenberg ME; Bird A
Nat Neurosci; 2013 Jul; 16(7):898-902. PubMed ID: 23770565
[TBL] [Abstract][Full Text] [Related]
9. Regenerative glutamate release in the hippocampus of Rett syndrome model mice.
Balakrishnan S; Mironov SL
PLoS One; 2018; 13(9):e0202802. PubMed ID: 30256804
[TBL] [Abstract][Full Text] [Related]
10. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.
Liu Y; Flamier A; Bell GW; Diao AJ; Whitfield TW; Wang HC; Wu Y; Schulte F; Friesen M; Guo R; Mitalipova M; Liu XS; Vos SM; Young RA; Jaenisch R
Neuron; 2024 Jun; 112(12):1943-1958.e10. PubMed ID: 38697112
[TBL] [Abstract][Full Text] [Related]
11. Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.
Johnson BS; Zhao YT; Fasolino M; Lamonica JM; Kim YJ; Georgakilas G; Wood KH; Bu D; Cui Y; Goffin D; Vahedi G; Kim TH; Zhou Z
Nat Med; 2017 Oct; 23(10):1203-1214. PubMed ID: 28920956
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome.
Kriaucionis S; Paterson A; Curtis J; Guy J; Macleod N; Bird A
Mol Cell Biol; 2006 Jul; 26(13):5033-42. PubMed ID: 16782889
[TBL] [Abstract][Full Text] [Related]
13. Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.
Smith ES; Smith DR; Eyring C; Braileanu M; Smith-Connor KS; Ei Tan Y; Fowler AY; Hoffman GE; Johnston MV; Kannan S; Blue ME
Neurobiol Learn Mem; 2019 Nov; 165():106962. PubMed ID: 30502397
[TBL] [Abstract][Full Text] [Related]
14. The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes.
Scaramuzza L; De Rocco G; Desiato G; Cobolli Gigli C; Chiacchiaretta M; Mirabella F; Pozzi D; De Simone M; Conforti P; Pagani M; Benfenati F; Cesca F; Bedogni F; Landsberger N
EMBO Mol Med; 2021 Apr; 13(4):e12433. PubMed ID: 33665914
[TBL] [Abstract][Full Text] [Related]
15. Selective Deletion of Methyl CpG Binding Protein 2 from Parvalbumin Interneurons in the Auditory Cortex Delays the Onset of Maternal Retrieval in Mice.
Rupert DD; Pagliaro AH; Choe J; Shea SD
J Neurosci; 2023 Oct; 43(40):6745-6759. PubMed ID: 37625856
[TBL] [Abstract][Full Text] [Related]
16. Activity-induced MeCP2 phosphorylation regulates retinogeniculate synapse refinement.
Tzeng CP; Whitwam T; Boxer LD; Li E; Silberfeld A; Trowbridge S; Mei K; Lin C; Shamah R; Griffith EC; Renthal W; Chen C; Greenberg ME
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310344120. PubMed ID: 37871205
[TBL] [Abstract][Full Text] [Related]
17. Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact.
Arezoumand KS; Roberts CT; Rastegar M
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672521
[TBL] [Abstract][Full Text] [Related]
18.
Ballinger EC; Schaaf CP; Patel AJ; de Maio A; Tao H; Talmage DA; Zoghbi HY; Role LW
eNeuro; 2019; 6(6):. PubMed ID: 31562178
[TBL] [Abstract][Full Text] [Related]
19. Rescue of hyperexcitability in hippocampal CA1 neurons from Mecp2 (-/y) mouse through surface potential neutralization.
Balakrishnan S; Mironov SL
PLoS One; 2018; 13(4):e0195094. PubMed ID: 29621262
[TBL] [Abstract][Full Text] [Related]
20. MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.
Frasca A; Spiombi E; Palmieri M; Albizzati E; Valente MM; Bergo A; Leva B; Kilstrup-Nielsen C; Bianchi F; Di Carlo V; Di Cunto F; Landsberger N
EMBO Mol Med; 2020 Jun; 12(6):e10270. PubMed ID: 32383329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
